Navigation Links
Lure of the home turf brings back NRI doctors

WE are seeing the first signs of a reverse brain drain in the healthcare sector, which is expected to only grow over time. The emergence of modern corporate and investorowned hospitals in the country is steadily luring more and more NRI doctors back to home turf. And unlike other sectors, where compensations at par with international levels have been the main draw, doctors are actually taking pay cuts to work in India. Fortis Healthcare, which is slated to open their first Rs 155-crore multi-speciality hospital at Mohali i June, have NRI's heading all their speciality divisions. ``We have nine doctors on board so far, of which 5 are from the US,'' says director, corporate marketing, Fortis Healthcare, Janak Bajwa. At Max, five out of the 35 doctors on board are from the US. Max recently opened up a diagnostic centre and two Dr Max clinics in the capital. The total planned investment for Delhi is in the region of Rs 400 crore, which will include 25 small clinics, 4 large diagnostic centres and 2 large hospitals. Apollo Hospitals, the country's first investor-owned hospital, has 150 full-time doctors on its panel in Delhi, of which 138 are NRI's. So what's making home the best place to be? One big draw is the emergence of truly world-class facilities with the increasing amount of private capital flowing into the business. ``Doctors expect a certain level of sophistication, which is now possible with the growing number of state-of-art hospitals in the country,'' says MD, Apollo Hospitals, Dr Yogi Mehrotra. Dr Rupinder Singh, who gave up 12 years in the US to work as head of emergency care at Fortis and Dr Nirmal Joshi, who put 15 years in the US behind him to work as medical director at Max, agree. ``I have been wanting to come back to India for the last two years, but didn't find a decent hospital that I would be comfortable working in. The Fortis facility is top of the line. Its like having a US hospital transplante
'"/>




Page: 1 2

Related medicine news :

1. Fame brings wealth but not health
2. Education in women brings sounder sleep
3. Cancer drug brings relief to patients of Crohn’s Diseas
4. India’s smallest premature baby brings immense joy to Indian parent
5. Cyclone Glenda brings Threat of Fatal Mosquito–borne Diseas
6. Stress brings about early onset of puberty
7. UV light brings a ray of hope for asthmatics
8. Two doctors suspended for wrong brain surgery
9. Thakur warns doctors
10. Negligent doctors asked to cough up 3 lakhs for death of patient
11. Spreading knowledge to doctors about herbal medicine

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Lure the home turf brings back NRI doctors

(Date:11/23/2009)...RIE,Minn.,Nov.23/PRNewswire/--XiotechCorporationto...entedanEmprise(TM)7000storagesystem,poweredbyIntel...tscurrentdatastorageneeds,enablefuturegrowthanddel...sacrossitsdatacenter. ,, MasonGeneral,locatedin...tworks magazine,s"MostWired-Rural"hospitalsin2008a...
(Date:11/23/2009)...NS,Nov.23/PRNewswire/--Thanksgivingweekendmarksthe...radition,theClassicrepresentsthesportsmanshipandpr...yofNewOrleansandthoseinattendance. ,, Forthecre...anceforsomedowntimebeforetheyworktotestandlaunchab...ofconstruction,PettyOfficerClaudeBovellandtheresto...
(Date:11/23/2009)... suggest that adding flaxseed oil to the diet coul...al women and women with diabetes, according to a r...l of Food Safety, Nutrition and Public Health . ,...h Center, in Cairo, Egypt, have studied the effect...seed oil in the diet might delay the onset of oste...
(Date:11/23/2009)...op plants genetically modified to produce bacteria...safe for people, have been planted on more than 20...ese Bt crops, named after the bacterium Bacillus ...ome major pests, allowing farmers to save money an...cide sprays. , However, since insects can evolve...
(Date:11/23/2009)...hemo regimen may improve patient outcomes, researc...y News) -- A new combination drug therapy shows pr...ract cancers, researchers say. , The study from...in Boston found that survival and tumor response i...angiogenesis inhibitor that has helped slow the gr...
Breaking Medicine News(10 mins):Health News:ISE Technology by Xiotech Helps Hospital Achieve Data Center Efficiency, Savings 2Health News:Nothing Is Like Being There 2Health News:Flaxseed oil and osteoporosis 2Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2
...Total U.S. Market for Women,s Health Devices Worth...swire/ - According to two market research reports ...nternational medical device, dental and pharmaceut...erilization devices, which grew over 54% in 2008, ...
...Unique fashion accessory adds a fun, playful pop o... good; Stylish low-cost pendants support disabled ...CLARA, Calif., May 5 - Ground-breaking Art of Po...unced it has finalized a licensing agreement with ...
... Out of adversity comes op...icant words uttered more than 250 years ago ring t...day. , New York, NY (Vocu...ring true for the Gift of Life Bone Marrow Found...
... The Better Hearing Instit... for Better Hearing and Speech Month: Listening Up...aring health affects job security, performance, an...t unaddressed hearing loss does not pose a barrier...
... ZyDoc Medical Transcripti...as chosen ZyDoc,s award-winning web-based e-transc...ents. , Hauppauge, New Yo...in business since 1994, has chosen ZyDoc,s award-w...
... Renowned Dentist Robert L... Cosmetic Dentistry is one of the few Doctors in P...n for oral sedation dentistry. , ...ly that the practice has earned its certification ...
Other Medicine News:Health News:U.S. Market for Female Sterilization Devices to Grow 36% in 2009 2Health News:Playing with Fashion: New 'Phenominoes' Pendants Feature Blind Artists' Phenomenal Artwork on Real Dominoes 2Health News:Playing with Fashion: New 'Phenominoes' Pendants Feature Blind Artists' Phenomenal Artwork on Real Dominoes 3Health News:Playing with Fashion: New 'Phenominoes' Pendants Feature Blind Artists' Phenomenal Artwork on Real Dominoes 4Health News:Playing with Fashion: New 'Phenominoes' Pendants Feature Blind Artists' Phenomenal Artwork on Real Dominoes 5Health News:Bone Marrow Registry to Launch Groundbreaking Fundraising Technology to Overcome Madoff Crisis 2Health News:Listening Up in a Down Economy: Better Hearing Institute Launches Public Service Campaign for Better Hearing and Speech Month 2Health News:Listening Up in a Down Economy: Better Hearing Institute Launches Public Service Campaign for Better Hearing and Speech Month 3Health News:Administrative Advantage Selects ZyDoc e-Transcription Platform for Clients 2Health News:Administrative Advantage Selects ZyDoc e-Transcription Platform for Clients 3Health News:Administrative Advantage Selects ZyDoc e-Transcription Platform for Clients 4Health News:Raleigh Comprehensive and Cosmetic Dentistry Earns Certification For Sedation Dentistry 2Health News:Raleigh Comprehensive and Cosmetic Dentistry Earns Certification For Sedation Dentistry 3
(Date:11/23/2009)...3/PRNewswire-FirstCall/-- LexiconPharmaceuticals,I...fromitsPhase2clinicalstudywith LX1031 inpatientswi...epresentedatGASTRO2009inLondonthisweek.Resultsfrom...mptoms,willbepresentedbyDr. PhilipM.Brown ,Lexicon...ber25,2009at2:30pmlocaltimeatthesessionentitled,"T...
(Date:11/23/2009)...RNewswire-FirstCall/--WoundManagementTechnologies,...rofspecialtymedicalproducts,announcedthatithasfile...ivemanagementbusinessupdatetoillustratethedevelopm...ncreased33.5%to$102,926vs.Q32008salesof$77,084. ,...27,892vs.Q32008shareholderequityof$(321,257) ,...
(Date:11/23/2009)...,Nov.23/PRNewswire-FirstCall/--Anesiva,Inc.(Nasdaq....U,PrichardhaveagreedtojointheAnesivaboardofdirect...esivaandArcionTherapeutics.Completionofthemergeris...previouslyannouncedAnesiva2009AnnualMeetingofStock...OysterPoint,Suite107A,SouthSanFrancisco,California...
Breaking Medicine Technology:Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Building Healthier America Announces the High Five Program Addressing Factors Affecting the Energy Levels of Overweight Men 57152 1Building Healthier America Announces the High Five Program Addressing Factors Affecting the Energy Levels of Overweight Men 57152 2Building Healthier America Announces the High Five Program Addressing Factors Affecting the Energy Levels of Overweight Men 57152 3Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 1Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 2Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 3Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 4Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 1Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 2Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 3Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 4
...r Validate Lipidomic-Based Therapeutics as an Emer...ery, SAN DIEGO, Sept. 4 Lpath, Inc. (OTC Bulleti... agents against bioactive,lipids, reported positiv...,and AMD with Lpathomab(TM), the company,s mouse m...cid). These results confirm the expected potent,an...
...la., Sept. 4 In an extensive analysis of,clinical...rolimus-eluting,Coronary Stent was associated with...need for reintervention compared to the Taxus Sten... This meta-analysis of 16 randomized,clinical tria... kind to,date, is now posted on the Journal of the...
Other Medicine Technology:Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process 2Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process 3Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 2Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 3Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 4
PROXIMATE ILS Circular Sizer Set
VALTRAC™ Reusable Purstring Device
EEA™ Reusable 34 mm Sizer
Calcitonin Assay Immunoradiometric (IRMA) Assay
Medicine Products: